Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of RNA-Based Vaccines market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of RNA-Based Vaccinesmarket, defines the market attractiveness level of RNA-Based Vaccines market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of RNA-Based Vaccines industry, describes the types of RNA-Based Vaccines market, the applications of major players and the market size, and deeply analyzes the current situation of the global RNA-Based Vaccines market and the development prospects and opportunities of RNA-Based Vaccines industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global RNA-Based Vaccines market in Chapter 13.
By Player:
Roche
Silenseed
Pfizer
Benitec Biopharma
RXi
Gradalis
Abbott Laboratories
Senesco
Quark
Sanofi-Aventis
Tekmira
Silence Therapeutics
Arrowhead Pharmaceuticals
Dicerna
Alnylam Pharmaceuticals
Calimmune Inc
By Type:
RNA-based Therapeutics
RNA-Based Vaccines
By End-User:
Cancer
Diabetes
Tuberculosis
Cardiovascular Diseases
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 RNA-Based Vaccines Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 RNA-Based Vaccines Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 RNA-Based Vaccines Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 RNA-Based Vaccines Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise RNA-Based Vaccines Market Analysis and Outlook to 2022
-
7.1 Global RNA-Based Vaccines Consumption (2017-2022)
-
7.2 United States RNA-Based Vaccines Consumption (2017-2022)
-
7.3 Europe RNA-Based Vaccines Consumption (2017-2022)
-
7.4 China RNA-Based Vaccines Consumption (2017-2022)
-
7.5 Japan RNA-Based Vaccines Consumption (2017-2022)
-
7.6 India RNA-Based Vaccines Consumption (2017-2022)
-
7.7 South Korea RNA-Based Vaccines Consumption (2017-2022)
8 Region and Country-wise RNA-Based Vaccines Market Analysis and Outlook to 2028
-
8.1 Global RNA-Based Vaccines Consumption Forecast (2022-2028)
-
8.2 United States RNA-Based Vaccines Consumption Forecast (2022-2028)
-
8.3 Europe RNA-Based Vaccines Consumption Forecast (2022-2028)
-
8.4 China RNA-Based Vaccines Consumption Forecast (2022-2028)
-
8.5 Japan RNA-Based Vaccines Consumption Forecast (2022-2028)
-
8.6 India RNA-Based Vaccines Consumption Forecast (2022-2028)
-
8.7 South Korea RNA-Based Vaccines Consumption Forecast (2022-2028)
9 Global RNA-Based Vaccines Market Outlook by Types and Applications to 2022
-
9.1 Global RNA-Based Vaccines Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global RNA-based Therapeutics Consumption and Growth Rate (2017-2022)
-
9.1.2 Global RNA-Based Vaccines Consumption and Growth Rate (2017-2022)
-
9.2 Global RNA-Based Vaccines Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Diabetes Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Tuberculosis Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Others Consumption and Growth Rate (2017-2022)
10 Global RNA-Based Vaccines Market Outlook by Types and Applications to 2028
-
10.1 Global RNA-Based Vaccines Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global RNA-based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global RNA-Based Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global RNA-Based Vaccines Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Tuberculosis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global RNA-Based Vaccines Import and Export Analysis (Top 5 Countries)
-
11.1 Global RNA-Based Vaccines Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global RNA-Based Vaccines Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 RNA-Based Vaccines Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global RNA-Based Vaccines Market Competitive Analysis
-
14.1 Roche
-
14.1.1 Roche Company Details
-
14.1.2 Roche RNA-Based Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Roche RNA-Based Vaccines Product and Service
-
14.2 Silenseed
-
14.2.1 Silenseed Company Details
-
14.2.2 Silenseed RNA-Based Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Silenseed RNA-Based Vaccines Product and Service
-
14.3 Pfizer
-
14.3.1 Pfizer Company Details
-
14.3.2 Pfizer RNA-Based Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Pfizer RNA-Based Vaccines Product and Service
-
14.4 Benitec Biopharma
-
14.4.1 Benitec Biopharma Company Details
-
14.4.2 Benitec Biopharma RNA-Based Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Benitec Biopharma RNA-Based Vaccines Product and Service
-
14.5 RXi
-
14.5.1 RXi Company Details
-
14.5.2 RXi RNA-Based Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 RXi RNA-Based Vaccines Product and Service
-
14.6 Gradalis
-
14.6.1 Gradalis Company Details
-
14.6.2 Gradalis RNA-Based Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Gradalis RNA-Based Vaccines Product and Service
-
14.7 Abbott Laboratories
-
14.7.1 Abbott Laboratories Company Details
-
14.7.2 Abbott Laboratories RNA-Based Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Abbott Laboratories RNA-Based Vaccines Product and Service
-
14.8 Senesco
-
14.8.1 Senesco Company Details
-
14.8.2 Senesco RNA-Based Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Senesco RNA-Based Vaccines Product and Service
-
14.9 Quark
-
14.9.1 Quark Company Details
-
14.9.2 Quark RNA-Based Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Quark RNA-Based Vaccines Product and Service
-
14.10 Sanofi-Aventis
-
14.10.1 Sanofi-Aventis Company Details
-
14.10.2 Sanofi-Aventis RNA-Based Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Sanofi-Aventis RNA-Based Vaccines Product and Service
-
14.11 Tekmira
-
14.11.1 Tekmira Company Details
-
14.11.2 Tekmira RNA-Based Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Tekmira RNA-Based Vaccines Product and Service
-
14.12 Silence Therapeutics
-
14.12.1 Silence Therapeutics Company Details
-
14.12.2 Silence Therapeutics RNA-Based Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Silence Therapeutics RNA-Based Vaccines Product and Service
-
14.13 Arrowhead Pharmaceuticals
-
14.13.1 Arrowhead Pharmaceuticals Company Details
-
14.13.2 Arrowhead Pharmaceuticals RNA-Based Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Arrowhead Pharmaceuticals RNA-Based Vaccines Product and Service
-
14.14 Dicerna
-
14.14.1 Dicerna Company Details
-
14.14.2 Dicerna RNA-Based Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Dicerna RNA-Based Vaccines Product and Service
-
14.15 Alnylam Pharmaceuticals
-
14.15.1 Alnylam Pharmaceuticals Company Details
-
14.15.2 Alnylam Pharmaceuticals RNA-Based Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 Alnylam Pharmaceuticals RNA-Based Vaccines Product and Service
-
14.16 Calimmune Inc
-
14.16.1 Calimmune Inc Company Details
-
14.16.2 Calimmune Inc RNA-Based Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.16.3 Calimmune Inc RNA-Based Vaccines Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of RNA-Based Vaccines
-
Figure RNA-Based Vaccines Picture
-
Table Global RNA-Based Vaccines Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global RNA-Based Vaccines Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global RNA-Based Vaccines Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global RNA-Based Vaccines Consumption by Country (2017-2022)
-
Figure United States RNA-Based Vaccines Consumption and Growth Rate (2017-2022)
-
Table Europe RNA-Based Vaccines Consumption and Growth Rate (2017-2022)
-
Figure China RNA-Based Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Japan RNA-Based Vaccines Consumption and Growth Rate (2017-2022)
-
Figure India RNA-Based Vaccines Consumption and Growth Rate (2017-2022)
-
Figure South Korea RNA-Based Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Global RNA-Based Vaccines Consumption Forecast by Country (2022-2028)
-
Figure United States RNA-Based Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe RNA-Based Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure China RNA-Based Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan RNA-Based Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure India RNA-Based Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea RNA-Based Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global RNA-based Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global RNA-Based Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Global Tuberculosis Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global RNA-based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global RNA-Based Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tuberculosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global RNA-Based Vaccines Import by Region (Top 5 Countries) (2017-2028)
-
Table Global RNA-Based Vaccines Export by Region (Top 5 Countries) (2017-2028)
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche RNA-Based Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche RNA-Based Vaccines Product and Service
-
Table Silenseed (Foundation Year, Company Profile and etc.)
-
Table Silenseed RNA-Based Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Silenseed RNA-Based Vaccines Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer RNA-Based Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer RNA-Based Vaccines Product and Service
-
Table Benitec Biopharma (Foundation Year, Company Profile and etc.)
-
Table Benitec Biopharma RNA-Based Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Benitec Biopharma RNA-Based Vaccines Product and Service
-
Table RXi (Foundation Year, Company Profile and etc.)
-
Table RXi RNA-Based Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table RXi RNA-Based Vaccines Product and Service
-
Table Gradalis (Foundation Year, Company Profile and etc.)
-
Table Gradalis RNA-Based Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gradalis RNA-Based Vaccines Product and Service
-
Table Abbott Laboratories (Foundation Year, Company Profile and etc.)
-
Table Abbott Laboratories RNA-Based Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories RNA-Based Vaccines Product and Service
-
Table Senesco (Foundation Year, Company Profile and etc.)
-
Table Senesco RNA-Based Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Senesco RNA-Based Vaccines Product and Service
-
Table Quark (Foundation Year, Company Profile and etc.)
-
Table Quark RNA-Based Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Quark RNA-Based Vaccines Product and Service
-
Table Sanofi-Aventis (Foundation Year, Company Profile and etc.)
-
Table Sanofi-Aventis RNA-Based Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi-Aventis RNA-Based Vaccines Product and Service
-
Table Tekmira (Foundation Year, Company Profile and etc.)
-
Table Tekmira RNA-Based Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tekmira RNA-Based Vaccines Product and Service
-
Table Silence Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Silence Therapeutics RNA-Based Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Silence Therapeutics RNA-Based Vaccines Product and Service
-
Table Arrowhead Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Arrowhead Pharmaceuticals RNA-Based Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Arrowhead Pharmaceuticals RNA-Based Vaccines Product and Service
-
Table Dicerna (Foundation Year, Company Profile and etc.)
-
Table Dicerna RNA-Based Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dicerna RNA-Based Vaccines Product and Service
-
Table Alnylam Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Alnylam Pharmaceuticals RNA-Based Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alnylam Pharmaceuticals RNA-Based Vaccines Product and Service
-
Table Calimmune Inc (Foundation Year, Company Profile and etc.)
-
Table Calimmune Inc RNA-Based Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Calimmune Inc RNA-Based Vaccines Product and Service
-
